A Study of ASP3082 in Adults With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

651

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Solid Tumor
Interventions
DRUG

ASP3082

Intravenous Infusion

DRUG

Cetuximab

Intravenous Infusion

DRUG

Leucovorin

Intravenous Infusion

DRUG

Oxaplatin

Intravenous Infusion

DRUG

Fluorouracil

Intravenous Infusion

DRUG

Irinotecan

Intravenous Infusion

DRUG

Nanoparticle albumin-bound-paclitaxel

Intravenous Infusion

DRUG

Gemcitabine

Intravenous Infusion

DRUG

Docetaxel

Intravenous Infusion

DRUG

Pembrolizumab

Intravenous Infusion

DRUG

Cisplatin

Intravenous Infusion

DRUG

Carboplatin

Intravenous Infusion

DRUG

Pemetrexed

Intravenous Infusion

Trial Locations (49)

10032

RECRUITING

Columbia University - Herbert Irving Comprehensive Cancer Center, New York

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

14263

RECRUITING

Roswell Park Cancer Institute, Buffalo

20007

RECRUITING

Georgetown University Hospital, Washington D.C.

22031

RECRUITING

NEXT Oncology - Virginia Cancer Specialists, Fairfax

32610

RECRUITING

University of Florida, Davis Cancer Center, Gainesville

32746

RECRUITING

Florida Cancer Specialist, Lake Mary

37203

TERMINATED

SCRI Oncology Partners, Nashville

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

44106

RECRUITING

Case Western, Cleveland

53792

RECRUITING

University of Wisconsin Hospital, Madison

63110

RECRUITING

Washington University School of Medicine, St Louis

66205

RECRUITING

University of Kansas Medical Center, Westwood

78229

RECRUITING

NEXT Oncology, San Antonio

80218

RECRUITING

Denver HealthONE Drug Development Unit, Denver

90404

RECRUITING

UCLA Santa Monica Hematology Oncology, Santa Monica

91010

RECRUITING

City of Hope National Medical Center, Duarte

97239

RECRUITING

Oregon Health and Science University, Portland

06520-8028

RECRUITING

Smilow Cancer Center at Yale New Haven Hospital, New Haven

34232-6422

RECRUITING

Florida Cancer Specialists & Research Institute Sarasota, Sarasota

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

RECRUITING

Dana Farber Cancer Institute, Boston

Unknown

RECRUITING

Beijing Cancer Hospital, Beijing

RECRUITING

Fudan University Shanghai Cancer Center, Xuhui District

RECRUITING

Site FR33003, La Tronche

RECRUITING

Site FR33002, Bordeaux

RECRUITING

Site FR33001, Lyon

RECRUITING

Site FR33005, Lyon

RECRUITING

Site FR33004, Villejuif

RECRUITING

Aichi Cancer Center, Nagoya

RECRUITING

National Cancer Center Hospital East, Kashiwa

RECRUITING

Shikoku Cancer Center, Matsuyama

RECRUITING

Hokkaido University Hospital, Sapporo

RECRUITING

Kanagawa Cancer Center, Yokohama

RECRUITING

Tohoku University Hospital, Sendai

RECRUITING

Kindai University Hospital, Sayama

RECRUITING

Shizuoka Cancer Center, Sunto-gun

RECRUITING

National Cancer Center Hospital, Chuo-ku

RECRUITING

Cancer Institute Hospital of JFCR, Koto-ku

RECRUITING

Yamaguchi University Hospital, Ube

RECRUITING

Osaka International Cancer Institute, Osaka

RECRUITING

Site KR82002, Seongnam-si

RECRUITING

Site KR82001, Jongno -Gu

RECRUITING

Site KR82003, Seodaemun-gu

RECRUITING

Site KR82004, Songpa-gu

RECRUITING

Site ES34001, Barcelona

RECRUITING

Site ES34004, Madrid

RECRUITING

Site ES34002, Málaga

RECRUITING

Site ES34003, Seville

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY